bdb001
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 15, 2018 (NCT03486301)
Timeline
Indications
Studied for
Mechanism of action
- Toll-like receptor 8AGONIST
TLR8 agonist
- Toll-like receptor 7AGONIST
TLR7 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04819373 | Phase 2 | Aug 30, 2021 | Birdie Biopharmaceuticals HK Limited, Seven and Eight Biopharmaceuticals Inc |
| NCT04196530 | Phase 1 | Nov 21, 2019 | Birdie Biopharmaceuticals HK Limited, Seven and Eight Biopharmaceuticals Inc |
| NCT03486301 | Phase 1 | Feb 15, 2018 | Birdie Biopharmaceuticals HK Limited |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Birdie Biopharmaceuticals HK Limited | For profit | 3 | 3 | 2 | 2018 |
| Seven and Eight Biopharmaceuticals Inc | For profit | 2 | 0 | 2 | 2019 |
2 organizations
Page 1 / 1